- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint alleged a world-renowned restaurant venue and buffet would be the main draw for an Invokana promotional meeting. Panel said venue and…
Anonymous complaint about a nurse-led consultancy. Panel found no proven breach for therapy review grants, but ruled breaches where an email linked…
Astellas admitted Code issues after three Betmiga videos with product claims appeared online via third parties. Panel ruled breaches for two Vimeo…
Complaint about a Nicorette online ad: use of an infant image and a “43% more effective” claim without absolute data. PMCPA Panel…
A GP complained about a Tresiba promo email. PMCPA found the cost comparison table and HbA1c messaging could mislead due to unclear…
AstraZeneca’s CHMP-opinion press release for benralizumab was ruled within scope of the ABPI Code and found misleading/unbalanced on efficacy and safety claims.…
Inter-company complaint about Victoza congress stand emphasising CV risk reduction. Panel found the overall message was within the type 2 diabetes context…
A leavepiece and journal ad for Bonviva used the headline claim “Building bones”. PMCPA ruled it implied a direct bone-forming (anabolic) effect,…
GSK challenged an AstraZeneca Symbicort SMART leavepiece for an unqualified ‘Rx… plus as needed’ dosing line. The Panel found it reflected the…
Allergan challenged Pfizer Inc’s support for two AAO 2006 meetings linked to a wax museum and a nightclub. Panel found Pfizer UK…
AstraZeneca-funded statins insert in The Pharmaceutical Journal was ruled promotional for Crestor, misleading on targets/licence/safety and missing prescribing info. Multiple Code breaches…
A GP alleged a Spiriva journal ad implied COPD cure. Panel found the audience would understand COPD is incurable and the wording…
A GP mailing for Aprovel/CoAprovel implied cardiovascular risk reduction from treating BP to target. PMCPA ruled the claims misleading and unsubstantiated, breaching…
A public complaint challenged a Rectogesic press release implying it aided fissure healing. PMCPA ruled the statement inaccurate (Clauses 9.1, 20.2) but…
Shire alerted the PMCPA that a Calcichew-D3 Forte ad (linked to a prior breach campaign) ran in MIMS despite instructions to destroy…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.